Ikena Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	52.85	119.89	59.92	232.22	162.49	82.08
Short-Term Investments	104.5	55.57	97.03	0	0	0
Cash & Cash Equivalents	157.35	175.47	156.95	232.22	162.49	82.08
Cash Growth	14.18%	11.80%	-32.41%	42.91%	97.96%	-
Other Current Assets	3.82	3.2	3.06	4.3	3.48	3.12
Total Current Assets	161.17	178.66	160.01	236.52	165.97	85.21
Property, Plant & Equipment	6.11	8.02	8.46	8.98	1.56	0.77
Other Long-Term Assets	5.51	5.41	3.79	2.39	0.87	0
Total Long-Term Assets	11.62	13.43	12.25	11.36	2.44	0.77
Total Assets	172.78	192.09	172.26	247.88	168.4	85.97
Accounts Payable	1.91	2.07	2.09	2.38	2.12	0.94
Deferred Revenue	0	0	9.16	24.78	55.76	64.96
Current Debt	3.44	3.56	1.91	1.85	0.19	0
Other Current Liabilities	4.82	8.58	8.34	-1.82	-29.74	-41.59
Total Current Liabilities	10.17	14.21	21.5	27.19	28.33	24.3
Long-Term Debt	6.3	7.18	3.79	5.14	0	0
Other Long-Term Liabilities	0.96	0.95	0	7.68	35.14	44.27
Total Long-Term Liabilities	7.27	8.13	3.79	12.81	35.14	44.27
Total Liabilities	17.44	22.34	25.29	40	63.47	68.57
Total Debt	9.75	10.74	5.69	6.99	0.19	0
Debt Growth	82.18%	88.58%	-18.49%	3655.91%	-	-
Retained Earnings	-298.53	-282.39	-214.22	-145.45	-111.34	-67.08
Comprehensive Income	-0.31	-0.05	-0.76	0	0	0
Shareholders' Equity	155.35	169.76	146.97	207.88	-101.05	-61.46
Net Cash / Debt	147.6	164.73	151.25	225.23	162.31	82.08
Net Cash / Debt Growth	11.43%	8.91%	-32.85%	38.77%	97.73%	-
Net Cash Per Share	3.06	3.95	4.18	8.05	58.69	31.00
Working Capital	151	164.46	138.51	209.33	137.64	60.91
Book Value Per Share	3.22	4.07	4.06	7.43	-36.54	-23.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).